Olfactory Disorder
Showing 1 - 25 of 25
Olfactory Disorder, Smell Disorder, Traumatic Brain Injury Trial in Kansas City (Smell Test)
Active, not recruiting
- Olfactory Disorder
- +3 more
- Smell Test
-
Kansas City, KansasUniversity of Kansas Medical Center
Oct 30, 2023
Loss of Smell, Olfactory Disorder Trial in London (Olfactory training)
Recruiting
- Loss of Smell
- Olfactory Disorder
- Olfactory training
-
London, Ontario, CanadaFanshawe College
Oct 4, 2023
Smell Dysfunction, Olfactory Disorder, Long COVID Trial (Trigeminal Nerve Stimulation (TNS), Active Smell Training (ST), Placebo
Not yet recruiting
- Smell Dysfunction
- +2 more
- Trigeminal Nerve Stimulation (TNS)
- +2 more
- (no location specified)
May 9, 2023
COVID-19-Associated Olfactory Dysfunction, Anosmia, Hyposmia Trial (Stellate Ganglion Block)
Completed
- Anosmia
- +3 more
- Stellate Ganglion Block
-
Saint Louis, MissouriWashington University School of Medicine/Barnes Jewish Hospital
Jan 5, 2023
Olfactory Disorder, Olfaction Disorders Trial in Philadelphia (Platelet rich plasma, Saline)
Enrolling by invitation
- Olfactory Disorder
- Olfaction Disorders
- Platelet rich plasma
- Saline
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Dec 22, 2022
Frailty, Perioperative/Postoperative Complications, Olfactory Disorder Trial in Brussels (Olfactory function testing, Edmonton
Recruiting
- Frailty
- +4 more
- Olfactory function testing
- +3 more
-
Brussels, BelgiumCliniques universitaires Saint-Luc
Nov 9, 2022
Olfactory Disorder Trial in Saint Louis (Smell training)
Completed
- Olfactory Disorder
- Smell training
-
Saint Louis, MissouriWashington University
Nov 3, 2022
Chronic Rhinosinusitis With Nasal Polyps, Olfactory Disorder Trial in London (Dupilumab 300 MG/2 ML Subcutaneous Solution
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Olfactory Disorder
- Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]
-
London, Ontario, CanadaSt. Joseph's Health Care
Aug 21, 2022
Olfactory Disorder Trial in Shanghai (Traditional Chinese Medicine CU Xiu Tang, Olfactory Training)
Recruiting
- Olfactory Disorder
- Traditional Chinese Medicine CU Xiu Tang
- Olfactory Training
-
Shanghai, Shanghai, ChinaEye & ENT Hospital
Jul 7, 2022
COVID-19, Olfactory Disorder, Anosmia Trial in Saint Louis (Gabapentin gelatin capsules 300mg, Placebo)
Enrolling by invitation
- COVID-19
- +4 more
- Gabapentin gelatin capsules 300mg
- Placebo
-
Saint Louis, MissouriWashington University
Jun 16, 2022
Oral and Olfactory Complications of Recovered COVID-19 Patients
Recruiting
- Oral Complication
- +2 more
- Gustatory and olfactory function test
- Molecular assessment of saliva
-
Gießen, Hesse, GermanyJustus-Liebig University
May 16, 2022
Olfactory Disorder, Anosmia, Viral Infection Trial in Saint Louis (Theophylline, Saline Nasal)
Completed
- Olfactory Disorder
- +4 more
- Theophylline
- Saline Nasal
-
Saint Louis, MissouriWashington University in St. Louis
Mar 7, 2022
Frailty, Perioperative/Postoperative Complications, Olfactory Disorder Trial in Brussels (Olfactory identification test,
Completed
- Frailty
- +2 more
- Olfactory identification test
- +2 more
-
Brussels, BelgiumCliniques universitaires Saint-Luc
Feb 23, 2022
Olfactory Disorder, Olfaction Disorders, Olfactory Nerve Injuries Trial in San Diego, Stanford (Injection into olfactory cleft)
Active, not recruiting
- Olfactory Disorder
- +6 more
- Injection into olfactory cleft
-
San Diego, California
- +1 more
Feb 22, 2022
Smoking Cessation, Olfactory Disorder Trial in Switzerland (ENDS (vaporizer/e-cig) and smoking cessation counseling, Smoking
Active, not recruiting
- Smoking Cessation
- Olfactory Disorder
- ENDS (vaporizer/e-cig) and smoking cessation counseling
- Smoking cessation counseling
-
Lausanne, Vaud, Switzerland
- +4 more
Feb 11, 2022
Covid19, Anosmia, Olfactory Disorder Trial in Saint Louis (Theophylline Powder)
Completed
- Covid19
- +7 more
- Theophylline Powder
-
Saint Louis, MissouriWashington University School of Medicine in Saint Louis
Feb 1, 2022
CAncer, NUtrition and Taste - Validation of CANUT-QVA
Completed
- Hematologic Cancer
- +5 more
- Evaluation of the 9 dimensions of the CANUT-QVA questionnaire
-
Pierre-Bénite, FranceHospices Civils de Lyon, Groupement Hospitalier Lyon Sud, Servic
Jul 6, 2021
Olfactory Disorder Trial in London (Olfactory retraining, corticosteroid nasal irrigation, smell household Items)
Withdrawn
- Olfactory Disorder
- Olfactory retraining
- +3 more
-
London, Ontario, CanadaSt. Joseph's Health Care
Feb 17, 2021
Covid19, SARS-CoV Infection, Olfactory Disorder Trial in Belém (Essence oils)
Enrolling by invitation
- Covid19
- +3 more
- Essence oils
-
Belém, PA, BrazilUnidade de Ensino E Assistência Em Fisioterapia E Terapia Ocupac
Feb 18, 2021
Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
Recruiting
- Olfactory Disorder
- +6 more
-
Cambridge, United Kingdom
- +2 more
Dec 10, 2020
Acromegaly, Olfactory Disorder Trial in Istanbul (OB volume, CCCRC test)
Completed
- Acromegaly
- Olfactory Disorder
- OB volume
- CCCRC test
-
Istanbul, Fatih, TurkeyBezmialem Vakif University
Mar 13, 2020
Olfactory Disorder Trial in Vancouver (Vitamin A)
Unknown status
- Olfactory Disorder
- Vitamin A
-
Vancouver, British Columbia, Canada
- +1 more
Sep 18, 2019
Olfactory Disorder Trial in Kansas City (Smell Test)
Unknown status
- Olfactory Disorder
- Smell Test
-
Kansas City, KansasUniversity of Kansas Medical Center
Jul 16, 2019
Olfactory Disorder Trial in Seattle (saline nasal irrigation)
Completed
- Olfactory Disorder
- saline nasal irrigation
-
Seattle, WashingtonUniversity of Washington
Dec 11, 2013